Skip to content
News Center
About Us Careers News Center Contact Us Legal Partner Programs Doing Business with Illumina Investors Illumina for Startups Customer Engagement Center

Corporate

Illumina @ A Glance

Infographic provides snapshot of the company, its markets, its portfolio and more

Illumina @ A Glance
27 June 2019

Download the PDF »

Previous Article
Next Article

Recent articles

Professor Emma Baple on bringing whole-genome sequencing into clinical research
Video: Professor Emma Baple on bringing whole-genome sequencing into clinical research
What is proteomics? A simple guide to understanding measuring proteins at scale
What is proteomics? A simple guide to understanding measuring proteins at scale
When sequencing isn’t enough: A global forum for finding answers
When sequencing isn’t enough: A global forum for finding answers
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.